Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1831 clinical trials
Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours

At least 3, or up to 6, evaluable Japanese patients with advanced solid tumours will be enrolled in each cohort to confirm the tolerability.

  • 0 views
  • 05 Aug, 2020
Consolidative Radiotherapy Versus Observation for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

This is a phase II, multicenter, randomized open-label and comparative study designed to evaluate whether local consolidative radiotherapy improves overall survival as compared with standard management in patients with limited metastatic urothelial bladder cancer and without progression following first-line systemic therapy. Each patient will be followed during 3 years from …

  • 2 views
  • 05 Aug, 2020
Combined Optokinetic Stimulation and Cueing-based Reading Therapy to Treat Hemispatial Neglect Following Stroke

Each treatment phase consists of 15 therapy sessions lasting 30 to 45 minutes. The outcome will be assessed at different time points, including established neuropsychological tests for spatial neglect and a clinical score of neglect-related functional disability.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life Activities

The aim of this project is to determine the behavioral effects of retinitis pigmentosa (RP) by the effects of performance reductions related to adapting to darkness and visual field restriction. Those assessments will be in real conditions but also in virtual reality (VR). This tool can be used to measure …

direct observation
cognitive disorders
visual loss
retinopathy
retinal degeneration
  • 0 views
  • 05 Aug, 2020
PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer

Patients with metastatic prostate cancer can undergo MRI-guided prostate Stereotactic body radiation therapy (SBRT) without significant adverse events, similar to what has been reported for patients with localized prostate cancer. We hypothesize that prostate SBRT will be well-tolerated in metastatic prostate cancer patients, with quality of life outcomes similar to …

prostate cancer
MRI
metastatic prostate cancer
adenocarcinoma of prostate
stereotactic body radiation therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

Approximately 20 patients (male and female) 4 and 17 years of age with a genetically confirmed diagnosis of full maternal UBE3A gene deletion (within 15q11.2-q13 region) will be enrolled.

  • 0 views
  • 16 Feb, 2024
  • 4 locations
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

The Quad Shot treatment schedule reduces the number of days needed to deliver the radiation treatments, which may be less disruptive to systemic therapy schedules.

cisplatin/pemetrexed
carboplatin-pemetrexed
systemic therapy
carboplatin
stage iv non-small cell lung cancer
  • 0 views
  • 16 Feb, 2024
  • 7 locations
Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy

The purpose of this additional part of the study is to test whether the study drug, nivolumab, is a safe treatment that will prevent participants' primary central nervous system lymphoma (PCNSL) from growing again (recurrence). Participants will be people with PCNSL who continue to have cell free tumor DNA (cfDNA) …

ffpe
nivolumab
platelet transfusion
serum bilirubin level
neutrophil count
  • 0 views
  • 05 Aug, 2020
Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT

Patients who are fit, have multiple brain metastases (5-25 lesions) and reasonable life expectancy (>6 months) will be recruited from NCCS over 2 years. Patients will be followed up the over the following year with imaging, toxicity data, quality of life, activities of daily living and cognitive measurements at set …

brain tumor
MET
radiotherapy
serum pregnancy test
hydrocephalus
  • 0 views
  • 16 Feb, 2024
  • 1 location
UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy

Assessment of interactions between race and vascular risk factors, brain amyloid levels measured with [C-11]PiB-PET, and cognitive status will be the primary outcome of this imaging study.

alzheimer's disease
amyloidosis
amyloid
  • 0 views
  • 16 Feb, 2024
  • 1 location